NRP2, a cell surface molecule widely present in pancreatic cancer cells, plays a crucial role in tumor cell growth, migration, invasion, and angiogenesis.[17] Monoclonal antibodies against NRP2 have been proposed as a potential strategy for pancreatic cancer treatment. This evidence concerns the gene NRP2 and pancreatic neoplasm.